AI-Native Scoping Reviews & Evidence Mapping

TEVAR is no longer just a less invasive alternative to open repair — across type B dissection, traumatic injury, and thoracic aneurysm, it has become a strategy whose success depends on timing, landing-zone judgment, branch preservation, and complication control. This review shows where TEVAR clearly wins, where the evidence is still conflicted, and which technical decisions most strongly shape survival, remodeling, and long-term failure.

This review shows that TCAR is not just another carotid stenting technique, but a potentially safer endovascular strategy with a recurrent signal for lower stroke and death risk than transfemoral CAS, especially when neuroprotection matters most. The full read is worth it because it clarifies where that advantage looks strongest, where the evidence is still mixed, and which anatomical, symptomatic, and restenotic subgroups may truly benefit from TCAR.

This review shows that tattooing is far more than cosmetic ink: it maps how tattoos can act as long-term biological exposures linked to inflammation, pigment migration, diagnostic confusion, allergic disease, and possible cancer signals, while also serving as powerful medical tools in reconstruction, localization, drug delivery, and wearable sensing. The full paper is worth reading because it turns a scattered and emotionally charged topic into a clinically useful evidence map of where tattooing helps, where it harms, and which risks, technologies, and unanswered questions matter most.

This paper shows where systematic reviews and scoping reviews truly diverge: one is built to answer narrow, bias-sensitive questions, the other to map broad, uncertain evidence landscapes. Read the full text to see how reporting quality, automation, rapid reviews, overviews, and emerging synthesis methods fit into one practical framework for choosing the right review design.

This review shows that chronic pain is not only a symptom burden, but a clinically important suicide-risk context shaped by depression, sleep disturbance, mental defeat, catastrophizing, opioid transitions, and functional loss. The full read is worth it because it maps exactly which pain populations and care settings carry the strongest signal, where the evidence is most consistent, and which modifiable targets may help move suicide prevention in pain care from intuition to strategy.

Statins are not just cholesterol drugs: across an enormous evidence base, this review shows how they may help protect healthspan and longevity by lowering recurrent vascular events and mortality, while also exposing the real trade-offs around diabetes risk, intolerance, and poor long-term adherence. The full paper is worth reading because it separates where statins most clearly extend durable cardiovascular protection from where the evidence becomes mixed, controversial, and potentially relevant to broader aging-related pathways such as inflammation, liver disease, and neurocognitive decline.

This paper shows that statins remain one of the strongest cardiovascular therapies, consistently linked to fewer major events and lower mortality across very large populations, but not without trade-offs such as diabetes risk, muscle symptoms, and rises in lipoprotein(a). The full paper is worth reading because it shows where the benefit is most convincing, where the risks matter most, and how to think more clearly about the real balance between protection and harm.

This paper shows that the age gap between spouses is not just a demographic detail, but a meaningful social and health signal linked to early childbirth, women’s mental health, intimate partner violence patterns, child outcomes, widowhood, and household power dynamics across very different societies. The full review is worth reading because it reveals where larger age gaps may increase vulnerability, where they paradoxically appear protective, and how modernization is reshaping one of the most overlooked structures inside marriage.

Sports first aid remains uneven across coaches, PE teachers, athletes, and venues, with major gaps in BLS/AED readiness, dental trauma, concussion recognition, and emergency planning. This evidence map shows which practical training models, responder systems, and infrastructure strategies can strengthen real-world emergency preparedness in sport.

Semaglutide is not just a weight-loss drug — this review maps how it reaches across obesity, diabetes, cardiovascular disease, kidney protection, liver disease, and emerging neurologic pathways, while separating strong evidence from hype. The full paper is worth reading because it shows where semaglutide truly delivers the biggest clinical gains, where the safety and durability limits begin, and which future uses may matter most.

Retraction does not end the life of bad science — this review shows how misconduct-driven papers can keep shaping citations, clinical thinking, and public belief long after formal withdrawal. Drawing on 129 references, it maps why retractions fail, where the system breaks, and why the hidden afterlife of invalid research matters far more than most readers realize.

Research automation is no longer a futuristic add-on — this review shows where it is already transforming science, from trial recruitment and evidence synthesis to laboratory workflows and multimodal data pipelines, often cutting manual work by more than 90% without sacrificing performance. Across 1,679 original studies, the paper maps not only where automation truly delivers speed, scale, and reproducibility, but also where human oversight remains the difference between safe acceleration and costly over-trust.